M&A Deal Summary

Kane Biotech Acquires FB Dermatology

On November 12, 2024, Kane Biotech acquired life science company FB Dermatology

Acquisition Highlights
  • This is Kane Biotech’s 1st transaction in the Life Science sector.
  • This is Kane Biotech’s 1st transaction in Italy.

M&A Deal Summary
Date 2024-11-12
Target FB Dermatology
Sector Life Science
Buyer(s) Kane Biotech
Deal Type Add-on Acquisition

Target

FB Dermatology

San Benedetto del Tronto, Italy
FB Dermatology is a biotechnology company offering innovative and exclusive patented solutions for tissue regeneration, dermatology conditions, and aesthetic alterations. FB Dermatology is present all over Europe as well as Israel, Australia, and New Zealand. FB Dermatology is based in San Benedetto del Tronto, Italy.

Search 200,577 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Kane Biotech

Winnipeg, Manitoba, Canada
Category Company
Founded 2001
Sector Life Science
Revenue 2M USD (2021)
DESCRIPTION

Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. Kane Biotech has a portfolio of biotechnologies, intellectual property (66 patents and patents pending as well as trade secrets and trademarks) and products developed by Kane Biotech's own biofilm research expertise and acquired from leading research institutions. DispersinB®, coactiv+™, coactiv+®, DermaKB™, DermaKB Biofilm™, and revyve™ are trademarks of Kane Biotech Inc. Kane Biotech was founded in 2001 and is based in Winnipeg, Manitoba.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
Country (Italy) 1 of 1
Year (2024) 1 of 1
Mergr

Product

Company

Legal